top of page

News

2025.08.29
澄清聲明

本公司目前並未委託任何投顧公司買賣本公司股票、要求匯款等情事。有關本公司相關資訊，請以公開資訊觀測站之公告為標準。

本公司呼籲，民眾在投資未上市有價證券前要停看聽，注意相關風險，並審慎確認所作的投資與交易，是透過合法的機構進行，以維護自身投資權益，避免發生損失時，無法獲得保障。

投資人遇有上開情事者，可檢具相關具體事證資訊，逕向內政部警政署反詐騙專線165、或法務部調查局陳情檢舉信箱提出檢舉，或向金管會檢舉轉請檢調單位查辦。

提醒您 (多一份電話確認，多一分保障)

螢幕擷取畫面 2024-03-04 151613.png

2024.03.04
[Discovery New Taiwan] Asclepiumm Co., Ltd.

NewTV.260

2023.11.22
Ophthalmology New Drug Development Innovation Island! Taking Stock of Multiple Therapies' Phase II and III Data from 8 Taiwanese Companies

Global Bio & Investment Monthly

2023.11.09
Seeing the suffering of disease - Dr. Min-Che Chen founded 'Asclepiumm Taiwan Co., Ltd. to save incurable patients"

Moneyweekly

2022.06.07
The era of great supervision is coming! Peptide drugs open up affordable new drug treatment vision and business opportunities

Commercial Times

NEWS5

2021.06.21
Asclepiumm Chen Min-Che has been sharpening his sword for 10 years and bravely entered the blue ocean of new peptide drugs

Global Bio & Investment Monthly

NEWS4

2020.10.21
New drug development strives for early authorization!? An analysis of the strategies of four companies

Global Bio & Investment Monthly

NEWS3

2019.11.19
Taiwan Biotechnology Association leads a delegation to participate in BIO Europe to help Taiwanese biotechnology companies explore the European market

Global Bio & Investment Monthly

2019.11.11
Yang Muh-Hwa identified the key LTβ as a new target for drug resistance

Global Bio & Investment Monthly

2017.03.22
Interview: Chen Min-Che – Founder & Managing Director, Asclepiumm, Taiwan

Pharmaboardroom

bottom of page